129 related articles for article (PubMed ID: 3554809)
1. Recombinant vaccinia virus LC16m0 or LC16m8 that expresses hepatitis B surface antigen while preserving the attenuation of the parental virus strain.
Morita M; Suzuki K; Yasuda A; Kojima A; Sugimoto M; Watanabe K; Kobayashi H; Kajima K; Hashizume S
Vaccine; 1987 Mar; 5(1):65-70. PubMed ID: 3554809
[TBL] [Abstract][Full Text] [Related]
2. Stability of recombinant vaccinia virus LC16m0 or LC16m8: preserved laboratory attenuation markers and conserved expression of inserted HBsAg gene.
Watanabe K; Morita M; Kojima A
Vaccine; 1989 Dec; 7(6):499-502. PubMed ID: 2609725
[TBL] [Abstract][Full Text] [Related]
3. Improved recombinant LC16m0 or LC16m8 vaccinia virus successfully expressing hepatitis B surface antigen.
Watanabe K; Kobayashi H; Kajiyama K; Morita M; Yasuda A; Gotoh H; Saeki S; Sugimoto M; Saito H; Kojima A
Vaccine; 1989 Feb; 7(1):53-9. PubMed ID: 2718607
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of an attenuated vaccinia virus strain, LC16m0, and its recombinant virus vaccines.
Sugimoto M; Yamanouchi K
Vaccine; 1994 Jun; 12(8):675-81. PubMed ID: 8091843
[TBL] [Abstract][Full Text] [Related]
5. Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.
Smith GL; Mackett M; Moss B
Nature; 1983 Apr; 302(5908):490-5. PubMed ID: 6835382
[TBL] [Abstract][Full Text] [Related]
6. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase].
Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D
Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422
[No Abstract] [Full Text] [Related]
7. Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.
Paoletti E; Lipinskas BR; Samsonoff C; Mercer S; Panicali D
Proc Natl Acad Sci U S A; 1984 Jan; 81(1):193-7. PubMed ID: 6320164
[TBL] [Abstract][Full Text] [Related]
8. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
Chelyapov NV; Antonova TP; Yanova NN; Chernos VI
Acta Virol; 1988 Sep; 32(5):409-16. PubMed ID: 2904735
[TBL] [Abstract][Full Text] [Related]
9. Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains.
Sugimoto M; Yasuda A; Miki K; Morita M; Suzuki K; Uchida N; Hashizume S
Microbiol Immunol; 1985; 29(5):421-8. PubMed ID: 2993828
[TBL] [Abstract][Full Text] [Related]
10. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype.
Buller RM; Smith GL; Cremer K; Notkins AL; Moss B
Nature; 1985 Oct 31-Nov 6; 317(6040):813-5. PubMed ID: 4058585
[TBL] [Abstract][Full Text] [Related]
11. [A recombinant vaccinia virus expressing the middle preS2-S envelope protein of the hepatitis B virus. The induction of humoral and cellular immunity by the immunization of laboratory animals].
Beliaev AS; Dmitriev IP; Ignat'ev GM; Mizenko GA; Putintseva NI; Sabirov AN; Samukov VV; Semënova LN; Ammosov AD; Rukavishnikov MIu
Dokl Akad Nauk SSSR; 1990; 314(2):488-91. PubMed ID: 2265587
[No Abstract] [Full Text] [Related]
12. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
Shida H; Hinuma Y; Hatanaka M; Morita M; Kidokoro M; Suzuki K; Maruyama T; Takahashi-Nishimaki F; Sugimoto M; Kitamura R
J Virol; 1988 Dec; 62(12):4474-80. PubMed ID: 3184271
[TBL] [Abstract][Full Text] [Related]
13. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
Flexner C; Hügin A; Moss B
Nature; 1987 Nov 19-25; 330(6145):259-62. PubMed ID: 3118219
[TBL] [Abstract][Full Text] [Related]
14. NYVAC: a highly attenuated strain of vaccinia virus.
Tartaglia J; Perkus ME; Taylor J; Norton EK; Audonnet JC; Cox WI; Davis SW; van der Hoeven J; Meignier B; Riviere M
Virology; 1992 May; 188(1):217-32. PubMed ID: 1566575
[TBL] [Abstract][Full Text] [Related]
15. The immunogenicity of recombinant LC16mO vaccinia virus harboring HBsAg gene in mice.
Watanabe K; Morita M; Sato T; Yausi K; Kojima A
Biologicals; 1991 Apr; 19(2):77-85. PubMed ID: 1888498
[TBL] [Abstract][Full Text] [Related]
16. Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I.
Kutinová L; Ludvíková V; Krystofová J; Otavová M; Simonová V; Nĕmecková S; Hainz P; Vonka V
Vaccine; 1996 Aug; 14(11):1045-52. PubMed ID: 8879101
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.
Taylor G; Stott EJ; Wertz G; Ball A
J Gen Virol; 1991 Jan; 72 ( Pt 1)():125-30. PubMed ID: 1990060
[TBL] [Abstract][Full Text] [Related]
18. [Experimental study of residual virulence of viral vaccine strains].
Makhlaĭ AA; Bektimirov TA; Borisevich SV; Mikhaĭlov VV; Perekrest VV; Podkuĭko VN; Kirillov VB; Levitov AT; Ruchko VM
Vopr Virusol; 1999; 44(2):75-8. PubMed ID: 10358902
[TBL] [Abstract][Full Text] [Related]
19. Vaccinia virus strain LC16m8 defective in the B5R gene keeps strong protection comparable to its parental strain Lister in immunodeficient mice.
Yokote H; Shinmura Y; Kanehara T; Maruno S; Kuranaga M; Matsui H; Hashizume S
Vaccine; 2015 Nov; 33(45):6112-9. PubMed ID: 26241947
[TBL] [Abstract][Full Text] [Related]
20. Selection of recombinant vaccinia viruses (Tian Tan strain) expressing hepatitis B virus surface antigen by using beta-galactosidase as a marker.
Liu GQ; Cao X; Zhu JM; Ren GF; Li HM; Xie YX; Peng W
Sci China B; 1990 Feb; 33(2):188-97. PubMed ID: 2111142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
